Oscar Health Inc. (NYSE:OSCR) finished Friday with a subtraction of -$0.03 to close at $6.31, a downside of -0.47 percent. An average of 1,221,400 shares of common stock have been traded in the last five days. There was a fall of -$0.85 in the past week, and it reached a new high 11 times over the past 12 months. The last 20 days have seen an average of 1,815,630 shares traded, while the 50-day average volume stands at 1,721,456.
OSCR stock has decreased by -19.31% in the last month. The company shares reached their 1-month lowest point of $6.24 on 08/25/23. With the stock rallying to its 52-week high on 06/13/23, shares of the company touched a low of $2.05 and a high of $9.89 in 52 weeks. It has reached a new high 34 times so far this year and achieved 156.50% or $3.85 in price. In spite of this, the price is down -36.20% from the 52-week high.
Insider Transactions
OSCR stock investors should be aware that Oscar Health Inc. (OSCR) stock had its last reported insider trading activity 9 days ago on Aug 17. In this transaction, the insider spent $52,526,500. President of Technology & CTO, Schlosser Mario, disposed of 235,000 shares at a price of $6.91 on Aug 15. The insider now owns more than $1,624,578 worth of shares. Prior to that, Chief Transformation Officer Blackley Richard Scott went on to Sale 23,955 shares at $8.39 each on Jun 06. An amount of $201,093 was transacted.
Valuation Metrics
Oscar Health Inc. (OSCR) stock’s beta is 1.09. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 0.28, the price-to-book (PB) ratio at 1.46, and the price-to-cash flow ratio at 9.12.
Financial Health
Further, the company has a long term debt to equity ratio of 0.31 and a total debt to equity ratio of 0.31 for the quarter ending June 29. Its gross profit as reported stood at -$610.08 million compared to revenue of $3.96 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Oscar Health Inc.’s return on assets was -10.60%.
Earnings Surprise
For the three-month period that ended June 29, Oscar Health Inc. had $298.39 million in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$15.53 million in the quarter, while revenues of -$39.77 million were shrunk -622.22%. The analyst consensus anticipated Oscar Health Inc.’s latest quarter earnings to come in at -$0.23 per share, but it turned out to be -$0.07, a 69.60% surprise. For the quarter, EBITDA amounted to -$5.46 million. At the end of the quarter ending June 29, Oscar Health Inc.’s stock balance sheet showed total debt was $368.66 million. Shareholders own equity worth $221.91 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Oscar Health Inc. (OSCR) price momentum. RSI 9-day as of the close on 25 August was 29.15%, suggesting the stock is oversold, with historical volatility in this time frame at 63.26%.
As of today, OSCR’s price is $6.69 -11.87% or -$0.85 from its 5-day moving average. OSCR is currently trading -15.87% lower than its 20-day SMA and -6.38% lower than its 100-day SMA. However, the stock’s current price level is -30.96% below the SMA50 and +104.21% above the SMA200.
The stochastic %K and %D were 3.71% and 7.04%, respectively, and the average true range (ATR) was 0.41. With the 14-day stochastic at 3.21% and the average true range at 0.43, the RSI (14) stands at 34.19%. The stock has reached -0.47 on the 9-day MACD Oscillator while the 14-day reading was at -0.61.
Analyst Ratings
BofA Securities upgraded Oscar Health Inc. (NYSE: OSCR) to a a Neutral rating in its most recent analyst report. Previously, the stock was rated as an Underperform.
What is OSCR’s price target for the next 12 months?
Analysts predict a range of price targets between $5.00 and $12.00, with a median target of $8.50. Taking a look at these predictions, the average price target given by analysts for Oscar Health Inc. (OSCR) stock is $8.43.
